Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Emmaus Medical, Inc.

Home Clinical Trial Sponsors and OrganizationsEmmaus Medical, Inc.

Emmaus Medical, Inc.

ACTIVE

21250 Hawthorne Blvd Ste 800, 加利福尼亚州洛杉矶县, California, United Stateswww.emmausmedical.comPublic51–100 employeesEstablished: 2000-01-01

Part of Emmaus Life Sciences, Inc.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

4

0 active

Approvals

2

Total approvals

Agencies

1

Regulatory bodies

Founded

2000

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

1

25.0%

Phase 2

1

25.0%

Phase 3

1

25.0%

Phase 4

1

25.0%

Trial Status Distribution

Completed

4

100.0%

Clinical Trials

Trials sponsored by this organization (4)

Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients

Jan 202113 participants

L-glutamine Treatment in Patients With Diverticulosis

Jul 20199 participants

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

May 2010230 participants

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Mar 200470 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

2

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials4
Approvals2
News

Back to Organizations